ES2059588T3 - Factor xiii para la prevencion de una hemorragia intraventricular. - Google Patents

Factor xiii para la prevencion de una hemorragia intraventricular.

Info

Publication number
ES2059588T3
ES2059588T3 ES89102471T ES89102471T ES2059588T3 ES 2059588 T3 ES2059588 T3 ES 2059588T3 ES 89102471 T ES89102471 T ES 89102471T ES 89102471 T ES89102471 T ES 89102471T ES 2059588 T3 ES2059588 T3 ES 2059588T3
Authority
ES
Spain
Prior art keywords
prevention
factor xiii
intraventricular hemorrhage
intraventricular
hemorrhage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89102471T
Other languages
English (en)
Spanish (es)
Inventor
Akira Shirahata
Minoru Uchida
Satoshi Tanaka
Kenichiro Tsumura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis KK
Original Assignee
Hoechst Japan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan Ltd filed Critical Hoechst Japan Ltd
Application granted granted Critical
Publication of ES2059588T3 publication Critical patent/ES2059588T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ES89102471T 1988-02-24 1989-02-14 Factor xiii para la prevencion de una hemorragia intraventricular. Expired - Lifetime ES2059588T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63039646A JPH01216939A (ja) 1988-02-24 1988-02-24 末熟児頭蓋内出血阻止剤

Publications (1)

Publication Number Publication Date
ES2059588T3 true ES2059588T3 (es) 1994-11-16

Family

ID=12558846

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89102471T Expired - Lifetime ES2059588T3 (es) 1988-02-24 1989-02-14 Factor xiii para la prevencion de una hemorragia intraventricular.

Country Status (12)

Country Link
US (1) US5114916A (enExample)
EP (1) EP0330049B1 (enExample)
JP (1) JPH01216939A (enExample)
KR (1) KR0137476B1 (enExample)
AT (1) ATE94070T1 (enExample)
AU (1) AU613154B2 (enExample)
CA (1) CA1332352C (enExample)
DE (1) DE68908913T2 (enExample)
DK (1) DK174978B1 (enExample)
ES (1) ES2059588T3 (enExample)
IE (1) IE63656B1 (enExample)
PT (1) PT89802B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612456A (en) * 1988-11-14 1997-03-18 Zymogenetics, Inc. Factor XIII compositions
AU3423493A (en) * 1991-12-31 1993-07-28 Zymogenetics Inc. Methods and compositions for reducing blood loss
US5525335A (en) * 1992-04-21 1996-06-11 Ajinomoto Co., Inc. Wound healing agent
DE69326349T2 (de) * 1992-11-12 2000-03-02 Mayberg, Marc R. Verwendung von lokal appliziertem faktor xiii zur verhinderung von blutungen
JPH07328108A (ja) * 1994-06-10 1995-12-19 Ajinomoto Co Inc 生体組織接着剤及び血液凝固剤
CA2338665C (en) 1998-08-06 2011-01-18 Mountain View Pharmaceuticals, Inc. Peg-urate oxidase conjugates and use thereof
JP2008510476A (ja) * 2004-08-27 2008-04-10 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 生物学的材料からのｘｉｉｉ因子ポリペプチドの精製
JP5086093B2 (ja) * 2004-11-23 2012-11-28 ジモジェネティクス、インコーポレイテッド 組換え型ヒトｘｉｉｉ因子の精製
WO2008051178A2 (en) * 2006-04-12 2008-05-02 Savient Pharmaceuticals, Inc. Purification of proteins with cationic surfactant
US8188224B2 (en) 2005-04-11 2012-05-29 Savient Pharmaceuticals, Inc. Variant forms of urate oxidase and use thereof
TWI418564B (zh) * 2005-04-11 2013-12-11 Savient Pharmaceuticals Inc 利用陽離子界面活性劑之蛋白質純化
EP4635567A3 (en) 2009-06-25 2025-12-03 Horizon Therapeutics USA, Inc. Methods and kits for preventing infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
US20200237881A1 (en) 2019-01-30 2020-07-30 Horizon Pharma Rheumatology Llc Reducing immunogenicity to pegloticase
CN110234340A (zh) 2016-11-11 2019-09-13 好利恩风湿病制药有限责任公司 泼尼松和尿酸酶分子的组合疗法及其用途
US12121566B2 (en) 2019-01-30 2024-10-22 Horizon Therapeutics Usa, Inc. Methods for treating gout
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3717708A (en) * 1968-10-24 1973-02-20 Cutter Lab Blood coagulation complex
DE2063070C3 (de) * 1970-12-22 1975-07-24 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines Arzneimittels mit fibrinstabilisierender Wirkung
DE3622642A1 (de) * 1986-07-05 1988-01-14 Behringwerke Ag Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung
ATE121776T1 (de) * 1986-09-19 1995-05-15 Zymogenetics Inc Expression des biologisch aktiven faktors xiii.

Also Published As

Publication number Publication date
CA1332352C (en) 1994-10-11
DE68908913D1 (de) 1993-10-14
EP0330049B1 (en) 1993-09-08
DK83889A (da) 1989-08-25
PT89802A (pt) 1989-10-04
EP0330049A2 (en) 1989-08-30
DK174978B1 (da) 2004-04-05
AU3024389A (en) 1989-08-24
ATE94070T1 (de) 1993-09-15
IE63656B1 (en) 1995-05-31
KR890012659A (ko) 1989-09-18
IE890580L (en) 1989-08-24
AU613154B2 (en) 1991-07-25
US5114916A (en) 1992-05-19
EP0330049A3 (en) 1991-01-30
DK83889D0 (da) 1989-02-23
PT89802B (pt) 1994-04-29
JPH0378850B2 (enExample) 1991-12-17
JPH01216939A (ja) 1989-08-30
DE68908913T2 (de) 1994-01-27
KR0137476B1 (ko) 1998-06-01

Similar Documents

Publication Publication Date Title
ES2059588T3 (es) Factor xiii para la prevencion de una hemorragia intraventricular.
ES2115589T3 (es) Medicamento que contiene acido r-alfa-liponico o acido s-alfa-liponico como sustancia activa.
DE69008545D1 (de) Durchstichkanüle für medizinische Zwecke mit Tropfkammer.
FI870034A7 (fi) Kertakäyttöinen injektioruisku.
DE58900505D1 (de) Medizinischer katheter mit schneidvorrichtung.
NO2002009I2 (no) Tiotropium
ES2001936A6 (es) Procedimiento para la preparacion de indoles sustituidos con heterociclos.
DE19375061I2 (de) Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung.
ATE425139T1 (de) Benzamidinderivate
DK0563093T4 (da) Præparat anvendt som terapeutisk middel mod kroniske virale hepatitissygdomme
ES2064389T3 (es) Composicion de espuma de silicona de baja viscosidad.
DK314487A (da) Benzoxepinderivat
ATE174221T1 (de) Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten
EP1004304A4 (en) COMPOSITION CONTAINING ASCORBIC ACID
FI882409A7 (fi) Hitsattava mikrohuokoinen harsolaastari lääkintäkäyttöön.
ES2085898T3 (es) Tratamiento de la enfermedad hepatobiliar con compuestos 15-cetoprostaglandina.
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
NO995800D0 (no) Anvendelse av oligosakkarid for forhindring av blodkoagulering i ekstrakorporeale blodkretser
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
PT785787E (pt) Utilizacao de derivados de 1,5-benzodiazepina para o controlo de esvaziamento gastrico em doentes com diabetes mellitus nao-insulino dependentes
SE8802040D0 (sv) New use
IT211928Z2 (it) Cappellotto di cop}rtura degli aghi, particolarmente per siringhe monouso.
EP0236636A3 (en) Use of clonidine derivatives for the preparation of ocular hemostatic agents
ATE67674T1 (de) Pharmazeutische zubereitungen mit heilender aktivitaet.
IT8920906A0 (it) Blocchetto di sicurezza per la prevenzione di punture accidentali con aghi di siringhe.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 330049

Country of ref document: ES